Priya is Addition’s Chief Business Officer, leading business development, and corporate strategy. Before joining Addition, she built and led Corporate Development functions at CARGO Therapeutics and Aiolos Bio (acquired by GSK). Priya began her career at Roche and Genentech, holding leadership roles across Global Product Strategy, Commercial, and Drug Development. She earned her MBA from the NYU Stern School of Business, a Master of Science from the University of Kansas, and a Bachelor of Engineering from the University of Madras. Priya is deeply committed to advancing transformative therapies for patients by uniting scientific innovation with strategic focus and impactful partnerships.